Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Identifying Predictors of Biomarker Testing in Metastatic Non-Small Cell Lung Cancer

Nicholas Robert, MD, Ontada, Irving, TX, discusses real-world biomarker testing rates for metastatic non–small cell lung cancer (mNSCLC) within The US Oncology Network, examining patient factors associated with rates of biomarker testing.

This research identified histologic and geographic factors associated with the likelihood of testing, as well as the significance of practice size, concluding that understanding clinical and social determinants of health is critical when evaluating interventions to improve testing rates. 

Advertisement

Advertisement

Advertisement